These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1883 related articles for article (PubMed ID: 33767447)

  • 1. Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England.
    Volz E; Mishra S; Chand M; Barrett JC; Johnson R; Geidelberg L; Hinsley WR; Laydon DJ; Dabrera G; O'Toole Á; Amato R; Ragonnet-Cronin M; Harrison I; Jackson B; Ariani CV; Boyd O; Loman NJ; McCrone JT; Gonçalves S; Jorgensen D; Myers R; Hill V; Jackson DK; Gaythorpe K; Groves N; Sillitoe J; Kwiatkowski DP; ; Flaxman S; Ratmann O; Bhatt S; Hopkins S; Gandy A; Rambaut A; Ferguson NM
    Nature; 2021 May; 593(7858):266-269. PubMed ID: 33767447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7.
    Davies NG; Jarvis CI; ; Edmunds WJ; Jewell NP; Diaz-Ordaz K; Keogh RH
    Nature; 2021 May; 593(7858):270-274. PubMed ID: 33723411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic Surveillance of SARS-CoV-2 Lineages Indicates Early Circulation of P.1 (Gamma) Variant of Concern in Southern Brazil.
    Wink PL; Ramalho R; Monteiro FL; Volpato FCZ; Willig JB; Lovison OVA; Zavascki AP; Barth AL; Martins AF
    Microbiol Spectr; 2022 Feb; 10(1):e0151121. PubMed ID: 35171035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic reconstruction of the SARS-CoV-2 epidemic in England.
    Vöhringer HS; Sanderson T; Sinnott M; De Maio N; Nguyen T; Goater R; Schwach F; Harrison I; Hellewell J; Ariani CV; Gonçalves S; Jackson DK; Johnston I; Jung AW; Saint C; Sillitoe J; Suciu M; Goldman N; Panovska-Griffiths J; ; ; Birney E; Volz E; Funk S; Kwiatkowski D; Chand M; Martincorena I; Barrett JC; Gerstung M
    Nature; 2021 Dec; 600(7889):506-511. PubMed ID: 34649268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020.
    Leung K; Shum MH; Leung GM; Lam TT; Wu JT
    Euro Surveill; 2021 Jan; 26(1):. PubMed ID: 33413740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England.
    Davies NG; Abbott S; Barnard RC; Jarvis CI; Kucharski AJ; Munday JD; Pearson CAB; Russell TW; Tully DC; Washburne AD; Wenseleers T; Gimma A; Waites W; Wong KLM; van Zandvoort K; Silverman JD; ; ; Diaz-Ordaz K; Keogh R; Eggo RM; Funk S; Jit M; Atkins KE; Edmunds WJ
    Science; 2021 Apr; 372(6538):. PubMed ID: 33658326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study.
    Patone M; Thomas K; Hatch R; Tan PS; Coupland C; Liao W; Mouncey P; Harrison D; Rowan K; Horby P; Watkinson P; Hippisley-Cox J
    Lancet Infect Dis; 2021 Nov; 21(11):1518-1528. PubMed ID: 34171232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A year living with SARS-CoV-2: an epidemiological overview of viral lineage circulation by whole-genome sequencing in Barcelona city (Catalonia, Spain).
    Andrés C; Piñana M; Borràs-Bermejo B; González-Sánchez A; García-Cehic D; Esperalba J; Rando A; Zules-Oña RG; Campos C; Codina MG; Blanco-Grau A; Colomer-Castell S; Martín MC; Castillo C; García-Comuñas K; Vásquez-Mercado R; Martins-Martins R; Saubi N; Campins-Martí M; Pumarola T; Quer J; Antón A
    Emerg Microbes Infect; 2022 Dec; 11(1):172-181. PubMed ID: 34842496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tracking SARS-CoV-2 lineage B.1.1.7 dissemination: insights from nationwide spike gene target failure (SGTF) and spike gene late detection (SGTL) data, Portugal, week 49 2020 to week 3 2021.
    Borges V; Sousa C; Menezes L; Gonçalves AM; Picão M; Almeida JP; Vieita M; Santos R; Silva AR; Costa M; Carneiro L; Casaca P; Pinto-Leite P; Peralta-Santos A; Isidro J; Duarte S; Vieira L; Guiomar R; Silva S; Nunes B; Gomes JP
    Euro Surveill; 2021 Mar; 26(10):. PubMed ID: 33706862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequencing Using a Two-Step Strategy Reveals High Genetic Diversity in the S Gene of SARS-CoV-2 after a High-Transmission Period in Tunis, Tunisia.
    Fares W; Ghedira K; Gdoura M; Chouikha A; Haddad-Boubaker S; Khedhiri M; Ayouni K; Lamari A; Touzi H; Hammemi W; Medeb Z; Sadraoui A; Hogga N; Ben Alaya N; Triki H
    Microbiol Spectr; 2021 Dec; 9(3):e0063921. PubMed ID: 34756072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 B.1.1.7 lineage rapidly spreads and replaces R.1 lineage in Japan: Serial and stationary observation in a community.
    Hirotsu Y; Omata M
    Infect Genet Evol; 2021 Nov; 95():105088. PubMed ID: 34560289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study.
    Bager P; Wohlfahrt J; Fonager J; Rasmussen M; Albertsen M; Michaelsen TY; Møller CH; Ethelberg S; Legarth R; Button MSF; Gubbels S; Voldstedlund M; Mølbak K; Skov RL; Fomsgaard A; Krause TG;
    Lancet Infect Dis; 2021 Nov; 21(11):1507-1517. PubMed ID: 34171231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple expansions of globally uncommon SARS-CoV-2 lineages in Nigeria.
    Ozer EA; Simons LM; Adewumi OM; Fowotade AA; Omoruyi EC; Adeniji JA; Olayinka OA; Dean TJ; Zayas J; Bhimalli PP; Ash MK; Maiga AI; Somboro AM; Maiga M; Godzik A; Schneider JR; Mamede JI; Taiwo BO; Hultquist JF; Lorenzo-Redondo R
    Nat Commun; 2022 Feb; 13(1):688. PubMed ID: 35115515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 introduction and lineage dynamics across three epidemic peaks in Southern Brazil: massive spread of P.1.
    Varela APM; Prichula J; Mayer FQ; Salvato RS; Sant'Anna FH; Gregianini TS; Martins LG; Seixas A; Veiga ABGD
    Infect Genet Evol; 2021 Dec; 96():105144. PubMed ID: 34798321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific allelic discrimination of N501Y and other SARS-CoV-2 mutations by ddPCR detects B.1.1.7 lineage in Washington State.
    Perchetti GA; Zhu H; Mills MG; Shrestha L; Wagner C; Bakhash SM; Lin MJ; Xie H; Huang ML; Mathias P; Bedford T; Jerome KR; Greninger AL; Roychoudhury P
    J Med Virol; 2021 Oct; 93(10):5931-5941. PubMed ID: 34170525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
    Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis.
    Nyberg T; Twohig KA; Harris RJ; Seaman SR; Flannagan J; Allen H; Charlett A; De Angelis D; Dabrera G; Presanis AM
    BMJ; 2021 Jun; 373():n1412. PubMed ID: 34130987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence and spread of the potential variant of interest (VOI) B.1.1.519 of SARS-CoV-2 predominantly present in Mexico.
    Rodríguez-Maldonado AP; Vázquez-Pérez JA; Cedro-Tanda A; Taboada B; Boukadida C; Wong-Arámbula C; Nuñez-García TE; Cruz-Ortiz N; Barrera-Badillo G; Hernández-Rivas L; López-Martínez I; Mendoza-Vargas A; Reyes-Grajeda JP; Alcaraz N; Peñaloza-Figueroa F; Gonzalez-Barrera D; Rangel-DeLeon D; Herrera-Montalvo LA; Mejía-Nepomuceno F; Hernández-Terán A; Mújica-Sánchez M; Becerril-Vargas E; Martínez-Orozco JA; Pérez-Padilla R; Salas-Hernández J; Sanchez-Flores A; Isa P; Matías-Florentino M; Ávila-Ríos S; Muñoz-Medina JE; Grajales-Muñiz C; Salas-Lais AG; Santos Coy-Arechavaleta A; Hidalgo-Miranda A; Arias CF; Ramírez-González JE
    Arch Virol; 2021 Nov; 166(11):3173-3177. PubMed ID: 34448936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comprehensive Molecular Epidemiological Analysis of SARS-CoV-2 Infection in Cyprus from April 2020 to January 2021: Evidence of a Highly Polyphyletic and Evolving Epidemic.
    Chrysostomou AC; Vrancken B; Koumbaris G; Themistokleous G; Aristokleous A; Masia C; Eleftheriou C; Iοannou C; Stylianou DC; Ioannides M; Petrou P; Georgiou V; Hatziyianni A; Lemey P; Vandamme AM; Patsalis PP; Kostrikis LG
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34207490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of a SARS-CoV-2 variant of concern in South Africa.
    Tegally H; Wilkinson E; Giovanetti M; Iranzadeh A; Fonseca V; Giandhari J; Doolabh D; Pillay S; San EJ; Msomi N; Mlisana K; von Gottberg A; Walaza S; Allam M; Ismail A; Mohale T; Glass AJ; Engelbrecht S; Van Zyl G; Preiser W; Petruccione F; Sigal A; Hardie D; Marais G; Hsiao NY; Korsman S; Davies MA; Tyers L; Mudau I; York D; Maslo C; Goedhals D; Abrahams S; Laguda-Akingba O; Alisoltani-Dehkordi A; Godzik A; Wibmer CK; Sewell BT; Lourenço J; Alcantara LCJ; Kosakovsky Pond SL; Weaver S; Martin D; Lessells RJ; Bhiman JN; Williamson C; de Oliveira T
    Nature; 2021 Apr; 592(7854):438-443. PubMed ID: 33690265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 95.